Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Amortization of Deferred Charges (2023 - 2025)

Historic Amortization of Deferred Charges for Sanara MedTech (SMTI) over the last 6 years, with Q3 2025 value amounting to $598172.0.

  • Sanara MedTech's Amortization of Deferred Charges rose 12814.27% to $598172.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 37016.6%. This contributed to the annual value of $838965.0 for FY2024, which is 1622862.98% up from last year.
  • Latest data reveals that Sanara MedTech reported Amortization of Deferred Charges of $598172.0 as of Q3 2025, which was up 12814.27% from $583920.0 recorded in Q2 2025.
  • In the past 5 years, Sanara MedTech's Amortization of Deferred Charges registered a high of $598172.0 during Q3 2025, and its lowest value of $2055.0 during Q3 2023.
  • Over the past 3 years, Sanara MedTech's median Amortization of Deferred Charges value was $262192.0 (recorded in 2024), while the average stood at $270835.4.
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first skyrocketed by 1335760.62% in 2024, then surged by 12814.27% in 2025.
  • Over the past 3 years, Sanara MedTech's Amortization of Deferred Charges (Quarter) stood at $3083.0 in 2023, then soared by 13357.61% to $414898.0 in 2024, then skyrocketed by 44.17% to $598172.0 in 2025.
  • Its Amortization of Deferred Charges was $598172.0 in Q3 2025, compared to $583920.0 in Q2 2025 and $411324.0 in Q1 2025.